title: Towards immunotherapeutic drugs and vaccines against multiple sclerosis.
abstract: Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system. Numerous treatment options are available to MS patients; however, these options need to be improved. Herein, we review the current drugs and therapeutic approaches available to MS patients, preclinical trial interventions and recent animal model studies for the potential therapy of MS. Since the current treatment of MS remains elusive and is limited, animal studies and clinical research offers an optimistic outlook.
authors.affiliation: Burnet Institute, Austin Campus, Immunology and Vaccine Laboratory, Studley Road, Heidelberg, Victoria 3084, Australia.
authors.forename: Maria
authors.initials: M
authors.lastname: Katsara
authors.forename: John
authors.initials: J
authors.lastname: Matsoukas
authors.forename: George
authors.initials: G
authors.lastname: Deraos
authors.forename: Vasso
authors.initials: V
authors.lastname: Apostolopoulos
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use*; D014612:Vaccines / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D010455:Peptides; D014612:Vaccines